Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty

Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty

Bibliographic Details
Main Authors: Matthew Bindewald, MD, Sonia Singla, DO, David Leiman, MD, Barr Baynton, MD, Harold S. Minkowitz, MD, Stewart McCallum, MD, Randall Mack, BS, Rosemary Keller, PhD, Alex Freyer, PharmD, Wei Du, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2017-09-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000526177.14165.f4

Internet

http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000526177.14165.f4

Similar Items